Abstract

Biphasic drug delivery systems are used for quick release of a specific amount of drug for immediate amelioration of a patient’s state, followed by sustained release, to avoid repeated administration. This type of delivery is often necessary for pain management and the treatment of many pathologies, such as migraines, hypertension, and insomnia. In this work, we propose a novel architecture of a biphasic release media that does not need the rapidly disintegrating layer and that allows for easily setting the sustained release rate. A drug-containing capsule is made by rolling up a thermally crosslinked gelatin strip on which drug reservoirs are formed by casting. The quick-release reservoir (QRR) is placed at the strip’s extremity, from which the rolling starts, while the sustained-release reservoir (SRR) is formed in the middle part of the strip. The strip is rolled around a cylinder that is a few millimeters wide, which is removed after rolling. The roll is stabilized by transglutaminase-catalyzed crosslinking of the consecutive shells. A biphasic release is successfully demonstrated with the use of model fluorescent drugs for single-dye and double-dye systems in phosphate-buffered saline (PBS) solution with pH = 7.4. In vitro, the drug from the QRR, placed at the walls of the cavity of the roll, is released immediately upon the capsule’s contact with the PBS solution. The drug from the SRR, embedded between the roll’s layers, diffuses steadily, with the lag time defined by the radial position of the reservoir.

Highlights

  • A good therapeutic effect can be achieved by quick release (QR) of a significant amount of a drug, called a “loading-dose”, enabling the drug to rapidly reach the therapeutic level in blood plasma, followed by sustained release (SR) of the “maintenance-dose”, holding the therapeutic concentration level for a therapeutically sufficient period of time

  • Swelling of capsules was explored at pH = 2, approximately corresponding to stomach level, at pH = 4.5, and at pH = 7.4 (Figure 2a)

  • The biphasic kinetics were achieved due to specific geometry of the capsules, rather than due to the different matrix disintegration rates, which is the method used in traditional bilayer tablet biphasic release systems

Read more

Summary

Introduction

A good therapeutic effect can be achieved by quick release (QR) of a significant amount of a drug, called a “loading-dose”, enabling the drug to rapidly reach the therapeutic level in blood plasma, followed by sustained release (SR) of the “maintenance-dose”, holding the therapeutic concentration level for a therapeutically sufficient period of time. This quick/slow biphasic drug treatment may be beneficial for pain management [1] and for treating the acute symptoms of diseases, such as migraines [2], insomnia [3] and hypertension [4]. One layer of the tablet provides QR of the drug due to the presence of a super disintegrant, such as croscarmellose sodium [8], while the second layer provides

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.